We are live on ! Find out more
ATRS

Antares Pharma, Inc.
ATRS

Delisted

ATRS was delisted on the 23rd of May, 2022.

Back to rankings

103 hedge funds and large institutions have $185M invested in Antares Pharma, Inc. in 2017 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 29 increasing their positions, 18 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

264% more call options, than puts

Call options by funds: $640K | Put options by funds: $176K

112% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 17

61% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 18

30% more capital invested

Capital invested by funds: $142M → $185M (+$43.3M)

21% more funds holding

Funds holding: 85 → 103 (+18)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
103
Holders Change
+18
Holders Change %
+21.18%
% of All Funds
2.57%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
36
Increased
29
Reduced
18
Closed
17
Calls
$640K
Puts
$176K
Net Calls
+$464K
Net Calls Change
+$222K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$17.8M
2
State Street
State Street
Massachusetts
+$5.54M
3
Northern Trust
Northern Trust
Illinois
+$3.88M
4
PA
Perceptive Advisors
New York
+$3.83M
5
Deutsche Bank
Deutsche Bank
Germany
+$2.45M

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$8.5M
2
BC
Broadfin Capital
New York
-$8.05M
3
Millennium Management
Millennium Management
New York
-$5.07M
4
KCM
Kingdon Capital Management
New York
-$2.41M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
BAS
26
Brown Advisory Securities
Maryland
$886K – – –
TA
27
Teachers Advisors
New York
$828K +$729K +257,124 New
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$820K +$722K +254,600 New
EI
29
EAM Investors
California
$810K – – –
GCP
30
GSA Capital Partners
United Kingdom
$651K +$573K +202,160 New
MCM
31
Moore Capital Management
New York
$644K – – –
ACM
32
Asymmetry Capital Management
California
$643K +$566K +199,655 New
Baird Financial Group
33
Baird Financial Group
Wisconsin
$629K -$4.82K -1,700 -0.9%
TDC
34
Thompson Davis & Co
Virginia
$621K +$352K +124,348 +182%
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$473K +$416K +146,925 New
Citadel Advisors
36
Citadel Advisors
Florida
$422K +$133K +47,010 +56%
M&T Bank
37
M&T Bank
New York
$419K +$142K +50,000 +63%
JP Morgan Chase
38
JP Morgan Chase
New York
$410K +$265K +93,538 +276%
CIBC Private Wealth Group
39
CIBC Private Wealth Group
Georgia
$403K – – –
Manulife (Manufacturers Life Insurance)
40
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$392K +$318K +112,191 +1,188%
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$391K +$344K +121,500 New
MWNA
42
Marshall Wace North America
New York
$387K +$365K +128,920 New
Two Sigma Investments
43
Two Sigma Investments
New York
$350K +$308K +108,685 New
MLICM
44
Metropolitan Life Insurance Company (MetLife)
New York
$335K +$295K +103,987 New
PCM
45
Prelude Capital Management
New York
$323K +$273K +96,330 +2,408%
V
46
Veritable
Delaware
$322K -$26.9K -9,500 -9%
PNC Financial Services Group
47
PNC Financial Services Group
Pennsylvania
$322K – – –
BP
48
Ballentine Partners
Massachusetts
$318K +$283K +100,000 New
RJFSA
49
Raymond James Financial Services Advisors
Florida
$307K +$270K +95,425 New
MC
50
Menta Capital
California
$297K +$261K +92,200 New
1
2
3 4 5

ATRS Hedge Fund Activity: Q2 2017 in Review

103 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Antares Pharma, Inc. (ATRS) for Q2 2017, worth a combined $185M — up 30% from $142M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new ATRS positions and 17 closed out — a net gain of 19 holders — while 29 added to existing stakes and 18 trimmed.

The largest buyer was BlackRock, adding an estimated $17.8M. The largest seller was Armistice Capital, cutting an estimated $8.5M.

  • 103 institutional investors held Antares Pharma, Inc. (ATRS) as of Q2 2017, up from 85 in Q1 2017.
  • Funds reported $185M of Antares Pharma, Inc. stock for Q2 2017, up 30% quarter-over-quarter.
  • 36 funds opened new Antares Pharma, Inc. positions in Q2 2017 and 17 closed out, a net change of +19 holders.
  • The largest Antares Pharma, Inc. buyer in Q2 2017 was BlackRock, an estimated $17.8M added.
  • The largest Antares Pharma, Inc. seller in Q2 2017 was Armistice Capital, an estimated $8.5M sold.

Based on aggregated 13F filings for Q2 2017.